Article
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
Blood - 15 Nov 1996
Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, Rahal D, Pedron S, Benedetti A, Scardoni M, Macrì E, Lestani M, Menestrina F, Pizzolo G, Scarpa A
Abstract excerpt
p21WAF1 (wild-type p53-activated fragment 1) is involved in the control of mammalian cell cycle through the binding and inhibition of cyclin-dependent kinases (Cdk). Because the product of WAF1 gene is a potent downstream effector of the p53 tumor-suppressor gene function, its pattern of cellular...
Topics
- Biomarkers
- Cell Cycle
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases
- Cyclins
- DNA Mutational Analysis
- Genes, p53
- Humans
- Lymphoma, Non-Hodgkin
- Neoplasm Proteins
- Phenotype
- Polymerase Chain Reaction
- Polymorphism, Single-Stranded Conformational